Nomoto; Kenichi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nomoto; Kenichi.The latest application filed is for "therapeutic agent for bile duct cancer".

Company Profile

1.8.11

Nomoto; Kenichi - Belmont MA
NOMOTO; Kenichi - Andover MA
Nomoto; Kenichi - Tukuba JP
Nomoto, Kenichi - Tukuba-shi JP
Nomoto; Kenichi - Tsuchiura JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Multikinase inhibitors for use in the treatment of cancer Grant 11,160,783 - Agoulnik , et al. November 2, 2	2021-11-02
Therapeutic Agent For Bile Duct Cancer App 20190111043 - SHIBATA; Tatsuhiro ; et al.	2019-04-18
Multikinase Inhibitors For Use In The Treatment Of Cancer App 20180353468 - Agoulnik; Sergei ; et al.	2018-12-13
Therapeutic Agent For Bile Duct Cancer App 20180015079 - SHIBATA; Tatsuhiro ; et al.	2018-01-18
Use of eribulin and lenvatinib as combination therapy for treatment of cancer Grant 9,549,922 - Nomoto , et al. January 24, 2	2017-01-24
Methods For Prognosing The Ability Of A Zearalenone Analog Compound To Treat Cancer App 20160291027 - NOMOTO; Kenichi ; et al.	2016-10-06
Multikinase Inhibitors For Use In The Treatment Of Cancer App 20150182496 - Agoulnik; Sergei ; et al.	2015-07-02
Multikinase inhibitors for use in the treatment of cancer Grant 8,937,056 - Agoulnik , et al. January 20, 2	2015-01-20
Use Of Eribulin And Lenvatinib As Combination Therapy For Treatment Of Cancer App 20150005343 - NOMOTO; Kenichi ; et al.	2015-01-01
Multikinase inhibitors for use in the treatment of cancer Grant 8,609,640 - Agoulnik , et al. December 17, 2	2013-12-17
Multikinase Inhibitors For Use In The Treatment Of Cancer App 20130303489 - Agoulnik; Sergei ; et al.	2013-11-14
Methods for prognosing the ability of a zearalenone analog compound to treat cancer App 20090170925 - Nomoto; Kenichi ; et al.	2009-07-02
Multikinase Inhibitors for Use in the Treatment of Cancer App 20090082313 - Agoulnik; Sergei ; et al.	2009-03-26
Human cancer cell line malignantly altered by expression of angiogenic factor Grant 6,649,367 - Yamamoto , et al. November 18, 2	2003-11-18
Human cancer cell line malignantly altered by expression of angiogenic factor App 20030003580 - Yamamoto, Yuji ; et al.	2003-01-02
Piperidine derivatives and therapeutic and preventive agents for arrhythmia containing same Grant 5,246,946 - Oinuma , et al. September 21, 1	1993-09-21
Piperidine derivative and pharmaceutical composition containing the same Grant 5,179,095 - Oinuma , et al. January 12, 1	1993-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.